title: The significance of the development of antinuclear antibodies during infliximab treatment.
authors.forename: Rosita
authors.initials: R
authors.lastname: Saraceno
authors.forename: Maria Sole
authors.initials: MS
authors.lastname: Chimenti
authors.forename: Sergio
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000974:Antibodies, Antinuclear / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D000974:Antibodies, Antinuclear; D000911:Antibodies, Monoclonal